License AgreementLicense Agreement • March 4th, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This License Agreement, made and entered into as of February 28, 2022 (“Agreement”), is by and between Yumanity, Inc., a Delaware corporation, having a place of business located at 40 Guest Street, Suite 4410, Boston, MA 02135(“Licensee”) and MIL 40G, LLC, a Delaware limited liability company having a place of business located at 40 Guest Street, Boston, MA 02135 (“SmartLabs”).
Termination of License AgreementTermination Agreement • March 4th, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Early Termination of License Agreement (“Termination Agreement”) is dated February 28, 2022 (“Execution Date”) and is entered into by and between Yumanity, Inc., previously known as, Yumanity Therapeutics, Inc., (“Licensee”) and MIL 40, LLC (“Licensor”).
